IMVT insider transactions
Immunovant Inc. (IMVT) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for IMVT
- Director Fromkin Andrew J. exercised 196,601 shares at a strike of $8.22 and sold $7,438,111 worth of shares (221,951 units at $33.51), decreasing direct ownership by 25% to 74,382 units (SEC Form 4)4 - Immunovant, Inc. (0001764013) (Issuer)
- Chief Operating Officer Gloria Melanie sold $101,072 worth of shares (3,115 units at $32.45), decreasing direct ownership by 1% to 242,107 units (SEC Form 4) to satisfy withholding obligation4 - Immunovant, Inc. (0001764013) (Issuer)
- Director Pande Atul exercised 6,000 shares at a strike of $8.43 and sold $192,000 worth of shares (6,000 units at $32.00) as part of a pre-agreed trading plan (SEC Form 4)4 - Immunovant, Inc. (0001764013) (Issuer)
- Director Susman Robert Graham sold $67,979 worth of shares (2,502 units at $27.17) as part of a pre-agreed trading plan, decreasing direct ownership by 6% to 36,394 units (SEC Form 4)4 - Immunovant, Inc. (0001764013) (Issuer)
- Chief Financial Officer Girao Tiago sold $763,011 worth of shares (25,760 units at $29.62), decreasing direct ownership by 9% to 247,596 units (SEC Form 4) (for withholding tax)4 - Immunovant, Inc. (0001764013) (Issuer)
- Chief Technology Officer Stout Jay S sold $81,573 worth of shares (2,754 units at $29.62), decreasing direct ownership by 1% to 251,685 units (SEC Form 4) (tax withholding)4 - Immunovant, Inc. (0001764013) (Issuer)
- SEC Form 4 filed by Van Tuyl Christopher4 - Immunovant, Inc. (0001764013) (Issuer)
- SEC Form 4 filed by Gloria Melanie4 - Immunovant, Inc. (0001764013) (Issuer)
- SEC Form 4 filed by Stout Jay S4 - Immunovant, Inc. (0001764013) (Issuer)
- SEC Form 4 filed by Torti Frank4 - Immunovant, Inc. (0001764013) (Issuer)
- SEC Form 4 filed by Fromkin Andrew J.4 - Immunovant, Inc. (0001764013) (Issuer)
- SEC Form 4 filed by Hughes Douglas J.4 - Immunovant, Inc. (0001764013) (Issuer)
- SEC Form 4 filed by Pande Atul4 - Immunovant, Inc. (0001764013) (Issuer)
- SEC Form 4 filed by Bauer Jake4 - Immunovant, Inc. (0001764013) (Issuer)
- SEC Form 4 filed by Susman Robert Graham4 - Immunovant, Inc. (0001764013) (Issuer)
- SEC Form 4 filed by Gloria Melanie4 - Immunovant, Inc. (0001764013) (Issuer)
- SEC Form 4 filed by Stout Jay S4 - Immunovant, Inc. (0001764013) (Issuer)
- SEC Form 4 filed by Van Tuyl Christopher4 - Immunovant, Inc. (0001764013) (Issuer)
- SEC Form 4 filed by Venker Eric4 - Immunovant, Inc. (0001764013) (Issuer)
- SEC Form 4 filed by Girao Tiago4 - Immunovant, Inc. (0001764013) (Issuer)
- SEC Form 4 filed by Venker Eric4 - Immunovant, Inc. (0001764013) (Issuer)
- SEC Form 4 filed by Van Tuyl Christopher4 - Immunovant, Inc. (0001764013) (Issuer)
- Chief Operating Officer Gloria Melanie sold $90,184 worth of shares (3,238 units at $27.85), decreasing direct ownership by 2% to 170,273 units (SEC Form 4)4 - Immunovant, Inc. (0001764013) (Issuer)
- Chief Technology Officer Stout Jay S sold $51,461 worth of shares (1,977 units at $26.03), decreasing direct ownership by 0.99% to 197,634 units (SEC Form 4)4 - Immunovant, Inc. (0001764013) (Issuer)
- Chief Technology Officer Stout Jay S sold $31,914 worth of shares (1,203 units at $26.53), decreasing direct ownership by 0.60% to 199,611 units (SEC Form 4)4 - Immunovant, Inc. (0001764013) (Issuer)
- Chief Legal Officer Van Tuyl Christopher sold $290,943 worth of shares (10,813 units at $26.91), decreasing direct ownership by 7% to 149,930 units (SEC Form 4)4 - Immunovant, Inc. (0001764013) (Issuer)
- Director Roivant Sciences Ltd. bought $349,999,986 worth of shares (16,666,666 units at $21.00), increasing direct ownership by 17% to 113,317,007 units (SEC Form 4)4 - Immunovant, Inc. (0001764013) (Issuer)
- Director Fromkin Andrew J. sold $517,189 worth of shares (22,249 units at $23.25), decreasing direct ownership by 21% to 85,852 units (SEC Form 4)4 - Immunovant, Inc. (0001764013) (Issuer)
- Director Hughes Douglas J. sold $348,665 worth of shares (15,000 units at $23.24), decreasing direct ownership by 11% to 120,773 units (SEC Form 4)4 - Immunovant, Inc. (0001764013) (Issuer)
- Chief Operating Officer Gloria Melanie sold $298,237 worth of shares (12,626 units at $23.62), decreasing direct ownership by 7% to 173,511 units (SEC Form 4)4 - Immunovant, Inc. (0001764013) (Issuer)
- Chief Medical Officer Geffner Michael sold $49,383 worth of shares (2,595 units at $19.03), decreasing direct ownership by 1% to 217,958 units (SEC Form 4)4 - Immunovant, Inc. (0001764013) (Issuer)
- Chief Technology Officer Stout Jay S sold $47,956 worth of shares (2,520 units at $19.03), decreasing direct ownership by 1% to 200,814 units (SEC Form 4)4 - Immunovant, Inc. (0001764013) (Issuer)
- Chief Medical Officer Geffner Michael sold $20,734 worth of shares (1,272 units at $16.30), decreasing direct ownership by 0.57% to 220,553 units (SEC Form 4)4 - Immunovant, Inc. (0001764013) (Issuer)
- Chief Technology Officer Stout Jay S sold $25,836 worth of shares (1,585 units at $16.30), decreasing direct ownership by 0.77% to 203,334 units (SEC Form 4)4 - Immunovant, Inc. (0001764013) (Issuer)
- SEC Form 4 filed by Chief Executive Officer Venker Eric4 - Immunovant, Inc. (0001764013) (Issuer)
- Chief Technology Officer Stout Jay S sold $50,911 worth of shares (2,805 units at $18.15), decreasing direct ownership by 1% to 204,919 units (SEC Form 4)4 - Immunovant, Inc. (0001764013) (Issuer)
- Chief Medical Officer Geffner Michael sold $43,288 worth of shares (2,385 units at $18.15), decreasing direct ownership by 1% to 221,825 units (SEC Form 4)4 - Immunovant, Inc. (0001764013) (Issuer)
- Chief Medical Officer Geffner Michael sold $19,998 worth of shares (1,160 units at $17.24), decreasing direct ownership by 0.51% to 224,210 units (SEC Form 4)4 - Immunovant, Inc. (0001764013) (Issuer)
- Chief Technology Officer Stout Jay S sold $26,188 worth of shares (1,519 units at $17.24), decreasing direct ownership by 0.73% to 207,724 units (SEC Form 4)4 - Immunovant, Inc. (0001764013) (Issuer)
- Chief Financial Officer Girao Tiago was granted 208,388 shares (SEC Form 4)4 - Immunovant, Inc. (0001764013) (Issuer)
- Director Susman Robert Graham was granted 25,016 shares (SEC Form 4)4 - Immunovant, Inc. (0001764013) (Issuer)
- Director Bauer Jake was granted 25,016 shares (SEC Form 4)4 - Immunovant, Inc. (0001764013) (Issuer)
- SEC Form 3 filed by new insider Girao Tiago3 - Immunovant, Inc. (0001764013) (Issuer)
- SEC Form 3 filed by new insider Bauer Jake3 - Immunovant, Inc. (0001764013) (Issuer)
- SEC Form 3 filed by new insider Susman Robert Graham3 - Immunovant, Inc. (0001764013) (Issuer)
- Chief Technology Officer Stout Jay S sold $28,471 worth of shares (1,925 units at $14.79), decreasing direct ownership by 0.91% to 209,243 units (SEC Form 4)4 - Immunovant, Inc. (0001764013) (Issuer)
- Chief Medical Officer Geffner Michael sold $34,742 worth of shares (2,349 units at $14.79), decreasing direct ownership by 1% to 225,370 units (SEC Form 4)4 - Immunovant, Inc. (0001764013) (Issuer)
- Chief Financial Officer Barnett Eva Renee sold $44,566 worth of shares (2,993 units at $14.89), decreasing direct ownership by 0.75% to 396,774 units (SEC Form 4)4 - Immunovant, Inc. (0001764013) (Issuer)
- Chief Executive Officer Salzmann Peter sold $123,900 worth of shares (8,321 units at $14.89), decreasing direct ownership by 0.70% to 1,178,191 units (SEC Form 4)4 - Immunovant, Inc. (0001764013) (Issuer)
- Chief Executive Officer Salzmann Peter sold $364,941 worth of shares (28,094 units at $12.99), decreasing direct ownership by 2% to 1,186,512 units (SEC Form 4)4 - Immunovant, Inc. (0001764013) (Issuer)
- Chief Legal Officer Van Tuyl Christopher was granted 50,787 shares, increasing direct ownership by 46% to 160,743 units (SEC Form 4)4 - Immunovant, Inc. (0001764013) (Issuer)
- Chief Operating Officer Gloria Melanie was granted 76,181 shares, increasing direct ownership by 69% to 186,137 units (SEC Form 4)4 - Immunovant, Inc. (0001764013) (Issuer)
- Chief Technology Officer Stout Jay S was granted 76,181 shares, increasing direct ownership by 54% to 216,172 units (SEC Form 4)4 - Immunovant, Inc. (0001764013) (Issuer)
- Chief Medical Officer Geffner Michael was granted 101,574 shares, increasing direct ownership by 77% to 233,888 units (SEC Form 4)4 - Immunovant, Inc. (0001764013) (Issuer)
- Chief Financial Officer Barnett Eva Renee was granted 88,878 shares, increasing direct ownership by 28% to 410,830 units (SEC Form 4)4 - Immunovant, Inc. (0001764013) (Issuer)
- Chief Executive Officer Salzmann Peter was granted 265,820 shares, increasing direct ownership by 28% to 1,214,606 units (SEC Form 4)4 - Immunovant, Inc. (0001764013) (Issuer)
- Director Pande Atul was granted 16,188 shares, increasing direct ownership by 19% to 102,851 units (SEC Form 4)4 - Immunovant, Inc. (0001764013) (Issuer)
- Director Hughes Douglas J. was granted 16,188 shares, increasing direct ownership by 14% to 135,773 units (SEC Form 4)4 - Immunovant, Inc. (0001764013) (Issuer)
- Director Fromkin Andrew J. was granted 16,188 shares, increasing direct ownership by 18% to 108,101 units (SEC Form 4)4 - Immunovant, Inc. (0001764013) (Issuer)
- Director Migausky George V was granted 16,188 shares, increasing direct ownership by 13% to 137,251 units (SEC Form 4)4 - Immunovant, Inc. (0001764013) (Issuer)